Thorium dioxide: still around.
Patients who have received thorium dioxide (Thorotrast) are at risk for hepatic and other malignancies. Because of the need to identify and carefully follow up these patients, we have presented three cases with the characteristic radiologic findings on plain films so that physicians unfamiliar with this appearance will now be aware of it.